Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trail

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
BR96 conjugates of highly potent anthracyclinesH Dalton King, Andrew J Staab, Kahnie Pham-Kaplita, et al.
Journal of Medicinal Chemistry|September 6, 2002
Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chainsH Dalton King, Gene M Dubowchik, Harold Mastalerz, et al.
Bioconjugate Chemistry|March 17, 1999
Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugatesH D King, D Yurgaitis, D Willner, et al.
Cancer Research|October 15, 1992
Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft modelsP A Trail, D Willner, S J Lasch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicinP A Trail, D Willner, A B Bianchi, et al.
Environmental Science & Technology|March 27, 2015
Impacts of potential CO2-reduction policies on air quality in the United StatesMarcus A Trail, Alexandra P Tsimpidi, Peng Liu, et al.
Biochemical and Biophysical Research Communications|June 27, 1998
Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesisW R Ji, L G Barrientos, M Llinás, et al.
Science (New York, N.Y.)|July 9, 1993
Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugatesP A Trail, D Willner, S J Lasch, et al.
Bioconjugate Chemistry|July 18, 2002
Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activityGene M Dubowchik, Raymond A Firestone, Linda Padilla, et al.
Bioconjugate Chemistry|November 1, 1993
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
BR96 conjugates of highly potent anthracyclinesH Dalton King, Andrew J Staab, Kahnie Pham-Kaplita, et al.
Journal of Medicinal Chemistry|September 6, 2002
Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chainsH Dalton King, Gene M Dubowchik, Harold Mastalerz, et al.
Bioconjugate Chemistry|March 17, 1999
Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugatesH D King, D Yurgaitis, D Willner, et al.
Cancer Research|October 15, 1992
Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft modelsP A Trail, D Willner, S J Lasch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicinP A Trail, D Willner, A B Bianchi, et al.
Environmental Science & Technology|March 27, 2015
Impacts of potential CO2-reduction policies on air quality in the United StatesMarcus A Trail, Alexandra P Tsimpidi, Peng Liu, et al.
Biochemical and Biophysical Research Communications|June 27, 1998
Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesisW R Ji, L G Barrientos, M Llinás, et al.
Science (New York, N.Y.)|July 9, 1993
Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugatesP A Trail, D Willner, S J Lasch, et al.
Bioconjugate Chemistry|July 18, 2002
Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activityGene M Dubowchik, Raymond A Firestone, Linda Padilla, et al.
Bioconjugate Chemistry|November 1, 1993
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.
Pageof 16